PharmD
Impact in
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
Papers in ⓘ
-
- Pharmaceutical Practices and Patient Outcomes 24
- Co-authors
- Bcps (46 shared papers)Anna D. Garrett (3 shared papers)Mary Wagner (1 shared paper)Vincent Chen (1 shared paper)Steven Kim (1 shared paper)Raymond C. Rosen (1 shared paper)Mona D. Shah (1 shared paper)J Bourret (2 shared papers)
- Journals
- The American Journal of Managed Care (5 papers)Drugs (1 paper)Journal of Allergy and Clinical Immunology (1 paper)Journal of General Internal Medicine (1 paper)SLEEP (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
PharmD
127 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Internal Medicine 509
- Cardiology and Cardiovascular Medicine 736
- Neurology 296
- Geriatrics and Gerontology 66
- Family Practice 26
Countries citing papers authored by PharmD
This map shows the geographic impact of PharmD's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PharmD with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PharmD more than expected).
Fields of papers citing papers by PharmD
This network shows the impact of papers produced by PharmD. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PharmD. The network helps show where PharmD may publish in the future.
Co-authors
The 25 scholars most cited alongside PharmD, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 150 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Idarucizumab for dabigatran reversal Hit paper breakdown → | 2015 | 890 |
| 2 | 1999 | 208 | |
| 3 | 2003 | 42 | |
| 4 | Treatment Patterns, Survival, and Healthcare Costs of Patients with Malignant Gliomas in a Large US Commercially Insured Population | 2014 | 28 |
| 5 | Economic Burden Associated With Parkinson Disease | 2009 | 21 |
| 6 | 1997 | 15 | |
| 7 | Analyzing Trends in Oral Anticancer Agents in an Academic Medical Facility | 2015 | 11 |
| 8 | 2015 | 8 | |
| 9 | Implementation of a Pharmacist-Managed Interdisciplinary Oral Chemotherapy Program in a Community Cancer Center | 2011 | 8 |
| 10 | Impact of Nonadherence to Cancer Therapy | 2012 | 7 |
| 11 | Treatment of rheumatoid arthritis: A review of recommendations and emerging therapy | 2011 | 7 |
| 12 | Chemotherapy Administration Sequence: A Review of the Literature and Creation of a Sequencing Chart | 2011 | 7 |
| 13 | Implications for multiple sclerosis in the era of the Affordable Care Act: the shifting managed care landscape. | 2014 | 6 |
| 14 | Fluorouracil Overdose: Clinical Manifestations and Comprehensive Management During and After Hospitalization | 2015 | 6 |
| 15 | Psychiatric Polypharmacy: The Good, the Bad, and the Ugly | 2007 | 5 |
| 16 | Comparing Grade 4 Neutropenia Associated with Pegfilgrastim Administered via the Onpro Device versus Manual Injection with a Prefilled Syringe | 2018 | 5 |
| 17 | Chemotherapy-Induced Diarrhea: Options for Treatment and Prevention | 2013 | 5 |
| 18 | Loss of Pregnancy in a Patient with Chronic Myeloid Leukemia During Treatment with Nilotinib | 2016 | 4 |
| 19 | Clinical Pharmacist Outreach to Increase Statin Use for Patients with Cardiovascular Disease in a Safety-Net Healthcare System. | 2021 | 4 |
| 20 | Beware of bisphosphonates and jaw disorder | 2006 | 4 |
About PharmD
PharmD is a scholar working on Geriatrics and Gerontology, Family Practice, Internal Medicine, Pharmacology and Genetics, having authored 150 papers that have together received 1.5k indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (24 papers), Pharmaceutical studies and practices (10 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers), Cancer Treatment and Pharmacology (8 papers), Economic and Financial Impacts of Cancer (7 papers), Atrial Fibrillation Management and Outcomes (7 papers), Pharmacy and Medical Practices (7 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). The work is most often cited by research in Internal Medicine (509 citations), Cardiology and Cardiovascular Medicine (736 citations), Neurology (296 citations), Geriatrics and Gerontology (66 citations) and Family Practice (26 citations). PharmD has collaborated with scholars based in United States and Canada. Frequent co-authors include Bcps, Anna D. Garrett, Mary Wagner, Vincent Chen, Steven Kim, Raymond C. Rosen, Mona D. Shah, J Bourret, F. Estelle R. Simons and Jay M. Portnoy. Their work appears in journals such as The American Journal of Managed Care, Drugs, Journal of Allergy and Clinical Immunology, Journal of General Internal Medicine and SLEEP.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.